Cargando…

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim of our analysis was to evaluate whether Lp(a)...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicero, Arrigo F. G., Fogacci, Federica, Derosa, Giuseppe, D’Angelo, Angela, Ventura, Fulvio, Rizzoli, Elisabetta, D’Addato, Sergio, Borghi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945189/
https://www.ncbi.nlm.nih.gov/pubmed/35327457
http://dx.doi.org/10.3390/biomedicines10030656
_version_ 1784673900214353920
author Cicero, Arrigo F. G.
Fogacci, Federica
Derosa, Giuseppe
D’Angelo, Angela
Ventura, Fulvio
Rizzoli, Elisabetta
D’Addato, Sergio
Borghi, Claudio
author_facet Cicero, Arrigo F. G.
Fogacci, Federica
Derosa, Giuseppe
D’Angelo, Angela
Ventura, Fulvio
Rizzoli, Elisabetta
D’Addato, Sergio
Borghi, Claudio
author_sort Cicero, Arrigo F. G.
collection PubMed
description In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim of our analysis was to evaluate whether Lp(a) levels could predict early vascular aging, and whether smaller apo(a) isoforms had a predictive value for vascular aging different than larger apo(a) isoforms in a cohort of subjects free from CVD. We considered the data of a subset of Brisighella Heart Study (BHS) participants free from CVD (462 men and 516 women) who were clinically evaluated during the 2012 BHS population survey. Predictors of arterial stiffness, measured as carotid-femoral pulse wave velocity (cfPWV) were estimated by the application of a step-wise linear regression model. In our cohort, there were 511 subjects with small apo(a) size and 467 subjects with large apo(a) isoforms. Subjects with larger apo(a) isoform sizes had significantly lower serum levels of Lp(a). In the BHS subpopulation sample, cfPWV was predicted by age, systolic blood pressure (SBP), serum levels of high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and sex, higher HDL-C serum levels and female sex associated with lower values of cfPWV. In subjects with smaller apo(a) isoform sizes, predictors of cfPWV were age, SBP, sex and serum levels of HDL-C, being higher HDL-C serum levels and female sex associated to lower values of cfPWV. In subjects with larger apo(a) isoform sizes, cfPWV was predicted by age, SBP, serum levels of Lp(a) and sex, with female sex associated with lower values of cfPWV. In our subpopulation sample, Lp(a) did not predict cfPWV. However, in subjects with large apo(a) isoform sizes, Lp(a) was a significant predictor of arterial stiffness.
format Online
Article
Text
id pubmed-8945189
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89451892022-03-25 Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study Cicero, Arrigo F. G. Fogacci, Federica Derosa, Giuseppe D’Angelo, Angela Ventura, Fulvio Rizzoli, Elisabetta D’Addato, Sergio Borghi, Claudio Biomedicines Article In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim of our analysis was to evaluate whether Lp(a) levels could predict early vascular aging, and whether smaller apo(a) isoforms had a predictive value for vascular aging different than larger apo(a) isoforms in a cohort of subjects free from CVD. We considered the data of a subset of Brisighella Heart Study (BHS) participants free from CVD (462 men and 516 women) who were clinically evaluated during the 2012 BHS population survey. Predictors of arterial stiffness, measured as carotid-femoral pulse wave velocity (cfPWV) were estimated by the application of a step-wise linear regression model. In our cohort, there were 511 subjects with small apo(a) size and 467 subjects with large apo(a) isoforms. Subjects with larger apo(a) isoform sizes had significantly lower serum levels of Lp(a). In the BHS subpopulation sample, cfPWV was predicted by age, systolic blood pressure (SBP), serum levels of high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and sex, higher HDL-C serum levels and female sex associated with lower values of cfPWV. In subjects with smaller apo(a) isoform sizes, predictors of cfPWV were age, SBP, sex and serum levels of HDL-C, being higher HDL-C serum levels and female sex associated to lower values of cfPWV. In subjects with larger apo(a) isoform sizes, cfPWV was predicted by age, SBP, serum levels of Lp(a) and sex, with female sex associated with lower values of cfPWV. In our subpopulation sample, Lp(a) did not predict cfPWV. However, in subjects with large apo(a) isoform sizes, Lp(a) was a significant predictor of arterial stiffness. MDPI 2022-03-11 /pmc/articles/PMC8945189/ /pubmed/35327457 http://dx.doi.org/10.3390/biomedicines10030656 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cicero, Arrigo F. G.
Fogacci, Federica
Derosa, Giuseppe
D’Angelo, Angela
Ventura, Fulvio
Rizzoli, Elisabetta
D’Addato, Sergio
Borghi, Claudio
Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
title Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
title_full Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
title_fullStr Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
title_full_unstemmed Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
title_short Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study
title_sort lipoprotein(a) serum levels predict pulse wave velocity in subjects in primary prevention for cardiovascular disease with large apo(a) isoforms: data from the brisighella heart study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945189/
https://www.ncbi.nlm.nih.gov/pubmed/35327457
http://dx.doi.org/10.3390/biomedicines10030656
work_keys_str_mv AT ciceroarrigofg lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT fogaccifederica lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT derosagiuseppe lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT dangeloangela lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT venturafulvio lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT rizzolielisabetta lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT daddatosergio lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT borghiclaudio lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy
AT lipoproteinaserumlevelspredictpulsewavevelocityinsubjectsinprimarypreventionforcardiovasculardiseasewithlargeapoaisoformsdatafromthebrisighellaheartstudy